Novel therapeutic uses and formulations of botulinum neurotoxins: a patent review (2012 – 2014)
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Novel therapeutic uses and formulations of botulinum neurotoxins: a patent review (2012 – 2014)
Authors
Keywords
-
Journal
EXPERT OPINION ON THERAPEUTIC PATENTS
Volume 25, Issue 6, Pages 675-690
Publisher
Informa Healthcare
Online
2015-04-06
DOI
10.1517/13543776.2015.1030337
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Isolation and Functional Characterization of the Novel Clostridium botulinum Neurotoxin A8 Subtype
- (2015) Skadi Kull et al. PLoS One
- Therapeutic use of botulinum toxin in migraine: mechanisms of action
- (2014) Roshni Ramachandran et al. BRITISH JOURNAL OF PHARMACOLOGY
- OnabotulinumtoxinA: How Deep Will It Go?
- (2014) Martin C. Michel EUROPEAN UROLOGY
- Pilot Study of Liposome-encapsulated OnabotulinumtoxinA for Patients with Overactive Bladder: A Single-center Study
- (2014) Hann-Chorng Kuo et al. EUROPEAN UROLOGY
- Thermoresponsive polymers: Insights into decisive hydrogel characteristics, mechanisms of gelation, and promising biomedical applications
- (2014) Maja Radivojša Matanović et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies
- (2014) Samir Mitragotri et al. NATURE REVIEWS DRUG DISCOVERY
- Persistence of Botulinum Neurotoxin A Subtypes 1-5 in Primary Rat Spinal Cord Cells
- (2014) Regina Clare Meyer Whitemarsh et al. PLoS One
- Development of an in vitro model to measure bioactivity of botulinum neurotoxin A in rat bladder muscle strips
- (2014) Janneke IM van Uhm et al. BMC Urology
- Engineered Botulinum Neurotoxins as New Therapeutics
- (2013) Geoffrey Masuyer et al. Annual Review of Pharmacology and Toxicology
- The role of Botulinum toxin injection in the management of achalasia
- (2013) Zeeshan Ramzan et al. CURRENT OPINION IN GASTROENTEROLOGY
- Rho as a Target to Promote Repair: Translation to Clinical Studies with Cethrin
- (2013) Lisa McKerracher et al. CURRENT PHARMACEUTICAL DESIGN
- OnabotulinumtoxinA 100 U Significantly Improves All Idiopathic Overactive Bladder Symptoms and Quality of Life in Patients with Overactive Bladder and Urinary Incontinence: A Randomised, Double-Blind, Placebo-Controlled Trial
- (2013) Christopher Chapple et al. EUROPEAN UROLOGY
- An Updated Systematic Review and Statistical Comparison of Standardised Mean Outcomes for the Use of Botulinum Toxin in the Management of Lower Urinary Tract Disorders
- (2013) Altaf Mangera et al. EUROPEAN UROLOGY
- Characterization of Botulinum Neurotoxin A Subtypes 1 Through 5 by Investigation of Activities in Mice, in Neuronal Cell Cultures, andIn Vitro
- (2013) Regina C. M. Whitemarsh et al. INFECTION AND IMMUNITY
- Characterization of SNARE Proteins in Human Pituitary Adenomas: Targeted Secretion Inhibitors as a New Strategy for the Treatment of Acromegaly?
- (2013) Edwin A. Garcia et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Very early reduction in efficacy of botulinum toxin therapy for cervical dystonia in patients with subsequent secondary treatment failure: a retrospective analysis
- (2013) Harald Hefter et al. JOURNAL OF NEURAL TRANSMISSION
- Analysis of Recruitment and Outcomes in the Phase I/IIa Cethrin Clinical Trial for Acute Spinal Cord Injury
- (2013) Lisa McKerracher et al. JOURNAL OF NEUROTRAUMA
- Molecular assembly of botulinum neurotoxin progenitor complexes
- (2013) D. A. Benefield et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Botulinum toxins: Mechanisms of action, antinociception and clinical applications
- (2013) Anthony Wheeler et al. TOXICOLOGY
- Clinical utility of different botulinum neurotoxin preparations
- (2013) Steven B. Abrams et al. TOXICON
- Effects of enzymatically inactive recombinant botulinum neurotoxin type A at the mouse neuromuscular junctions
- (2013) Padmamalini Baskaran et al. TOXICON
- The life history of a botulinum toxin molecule
- (2013) Lance Simpson TOXICON
- Content of Botulinum Neurotoxin in Botox®/Vistabel®, Dysport®/Azzalure®, and Xeomin®/Bocouture®
- (2013) Jürgen Frevert Drugs in research & development
- Structure of a Bimodular Botulinum Neurotoxin Complex Provides Insights into Its Oral Toxicity
- (2013) Kwangkook Lee et al. PLoS Pathogens
- Purification and Characterization of a Novel Subtype A3 Botulinum Neurotoxin
- (2012) William H. Tepp et al. APPLIED AND ENVIRONMENTAL MICROBIOLOGY
- Immunogenicity Issues Related to Botulinum Toxins in Clinical Use Cannot Be Answered by Speculation About Product Characteristics
- (2012) Andy Pickett BIODRUGS
- Immunogenicity and Long-Term Efficacy of Botulinum Toxin Type B in the Treatment of Cervical Dystonia
- (2012) Robert B. Chinnapongse et al. CLINICAL NEUROPHARMACOLOGY
- Spread of OnabotulinumtoxinA After Bladder Injection. Experimental Study Using the Distribution of Cleaved SNAP-25 as the Marker of the Toxin Action
- (2012) Ana Coelho et al. EUROPEAN UROLOGY
- Targeted delivery into motor nerve terminals of inhibitors for SNARE-cleaving proteases via liposomes coupled to an atoxic botulinum neurotoxin
- (2012) Om P. Edupuganti et al. FEBS Journal
- Human synaptotagmin-II is not a high affinity receptor for botulinum neurotoxin B and G: Increased therapeutic dosage and immunogenicity
- (2012) Jasmin Strotmeier et al. FEBS LETTERS
- Botulinum neurotoxin D-C uses synaptotagmin I and II as receptors, and human synaptotagmin II is not an effective receptor for type B, D-C and G toxins
- (2012) Lisheng Peng et al. JOURNAL OF CELL SCIENCE
- A botulinum toxin–derived targeted secretion inhibitor downregulates the GH/IGF1 axis
- (2012) Emmanuel Somm et al. JOURNAL OF CLINICAL INVESTIGATION
- Doxil® — The first FDA-approved nano-drug: Lessons learned
- (2012) Yechezkel (Chezy) Barenholz JOURNAL OF CONTROLLED RELEASE
- Immunogenicity of botulinum toxins
- (2012) Markus Naumann et al. JOURNAL OF NEURAL TRANSMISSION
- A Novel Strategy for Development of Recombinant Antitoxin Therapeutics Tested in a Mouse Botulism Model
- (2012) Jean Mukherjee et al. PLoS One
- Potent Neutralization of Botulinum Neurotoxin/B by Synergistic Action of Antibodies Recognizing Protein and Ganglioside Receptor Binding Domain
- (2012) Changchun Chen et al. PLoS One
- Endoscopic approaches to treatment of achalasia
- (2012) Stavros N. Stavropoulos et al. Therapeutic Advances in Gastroenterology
- Codon usage: Nature's roadmap to expression and folding of proteins
- (2011) Evelina Angov Biotechnology Journal
- Neurotherapeutics to inhibit exocytosis from sensory neurons for the control of chronic pain
- (2011) J Oliver Dolly et al. CURRENT OPINION IN PHARMACOLOGY
- Contemporary Management of Lower Urinary Tract Disease With Botulinum Toxin A: A Systematic Review of Botox (OnabotulinumtoxinA) and Dysport (AbobotulinumtoxinA)
- (2011) Altaf Mangera et al. EUROPEAN UROLOGY
- Novel therapeutics based on recombinant botulinum neurotoxins to normalize the release of transmitters and pain mediators
- (2011) J. Oliver Dolly et al. FEBS Journal
- Exchange of the HCC domain mediating double receptor recognition improves the pharmacodynamic properties of botulinum neurotoxin
- (2011) Andreas Rummel et al. FEBS Journal
- Innocuous full-length botulinum neurotoxin targets and promotes the expression of lentiviral vectors in central and autonomic neurons
- (2011) V B O'Leary et al. GENE THERAPY
- A Phase I/IIa Clinical Trial of a Recombinant Rho Protein Antagonist in Acute Spinal Cord Injury
- (2011) Michael G. Fehlings et al. JOURNAL OF NEUROTRAUMA
- C3 Peptide Promotes Axonal Regeneration and Functional Motor Recovery after Peripheral Nerve Injury
- (2011) Stefanie C. Huelsenbeck et al. Neurotherapeutics
- Updates on the antinociceptive mechanism hypothesis of botulinum toxin A
- (2011) K. Roger Aoki et al. PARKINSONISM & RELATED DISORDERS
- Characterization of diffusion and duration of action of a new botulinum toxin type A formulation
- (2011) Hongran F. Stone et al. TOXICON
- OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial
- (2010) SK Aurora et al. CEPHALALGIA
- OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial
- (2010) HC Diener et al. CEPHALALGIA
- Botulinum toxin in the treatment of diffuse esophageal spasm
- (2010) M. Bashashati et al. DISEASES OF THE ESOPHAGUS
- Adverse Events of Intravesical Botulinum Toxin A Injections for Idiopathic Detrusor Overactivity: Risk Factors and Influence on Treatment Outcome
- (2010) Hann-Chorng Kuo et al. EUROPEAN UROLOGY
- Intravesical instillation of botulinum toxin A: an in vivo murine study and pilot clinical trial
- (2010) Jan Krhut et al. INTERNATIONAL UROLOGY AND NEPHROLOGY
- A Dileucine in the Protease of Botulinum Toxin A Underlies Its Long-lived Neuroparalysis
- (2010) Jiafu Wang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Injectable Biodegradable Hydrogels
- (2010) Minh Khanh Nguyen et al. MACROMOLECULAR BIOSCIENCE
- Strategies in the design of nanoparticles for therapeutic applications
- (2010) Robby A. Petros et al. NATURE REVIEWS DRUG DISCOVERY
- Characterization of Botulinum Neurotoxin Type A Neutralizing Monoclonal Antibodies and Influence of Their Half-Lives on Therapeutic Activity
- (2010) Christelle Mazuet et al. PLoS One
- Targeting botulinum neurotoxin persistence by the ubiquitin-proteasome system
- (2010) Y. C. Tsai et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeted Secretion Inhibitors—Innovative Protein Therapeutics
- (2010) Foster Keith et al. Toxins
- Neutralizing Antibodies and Secondary Therapy Failure After Treatment With Botulinum Toxin Type A
- (2009) Oliver Lange et al. CLINICAL NEUROPHARMACOLOGY
- Signaling Through Rho GTPase Pathway as Viable Drug Target
- (2009) Qun Lu et al. CURRENT MEDICINAL CHEMISTRY
- Neuro-exocytosis: botulinum toxins as inhibitory probes and versatile therapeutics☆
- (2009) J Oliver Dolly et al. CURRENT OPINION IN PHARMACOLOGY
- Combined treatment of achalasia - botulinum toxin injection followed by pneumatic dilatation: long-term results
- (2009) R. Kroupa et al. DISEASES OF THE ESOPHAGUS
- Safety and tolerability of onabotulinumtoxinA in the treatment of facial lines: A meta-analysis of individual patient data from global clinical registration studies in 1678 participants
- (2009) Mitchell F. Brin et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Urodynamic and Immunohistochemical Evaluation of Intravesical Botulinum Toxin A Delivery Using Liposomes
- (2009) Yao-Chi Chuang et al. JOURNAL OF UROLOGY
- Receptor and substrate interactions of clostridial neurotoxins
- (2009) Axel T. Brunger et al. TOXICON
- Production of catalytically inactive BoNT/A1 holoprotein and comparison with BoNT/A1 subunit vaccines against toxin subtypes A1, A2, and A3
- (2009) Robert P. Webb et al. VACCINE
- Galanin – 25 years with a multitalented neuropeptide
- (2008) K. Mitsukawa et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Intravesical Botulinum Toxin A Administration Inhibits COX-2 and EP4 Expression and Suppresses Bladder Hyperactivity in Cyclophosphamide-Induced Cystitis in Rats
- (2008) Yao-Chi Chuang et al. EUROPEAN UROLOGY
- A 29-amino acid fragment of Clostridium botulinum C3 protein enhances neuronal outgrowth, connectivity, and reinnervation
- (2008) Markus Höltje et al. FASEB JOURNAL
- Novel Chimeras of Botulinum Neurotoxins A and E Unveil Contributions from the Binding, Translocation, and Protease Domains to Their Functional Characteristics
- (2008) Jiafu Wang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- In situ gelling stimuli-sensitive block copolymer hydrogels for drug delivery
- (2008) Chaoliang He et al. JOURNAL OF CONTROLLED RELEASE
- Assessment: Botulinum neurotoxin in the treatment of autonomic disorders and pain (an evidence-based review)
- (2008) M. Naumann et al. NEUROLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started